News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleVitamin C Boosts Placental Health, Changes Gene Activity in Smokers
December 5, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
UTHealth Houston and Texas Tech Health El Paso Announce Research Partnership for Greater Impact on Underserved Communities
December 5, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Welcome Evo, Generative AI for the Genome
December 4, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Reconstructing the Path of a Seizure
December 3, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
New Path for a Gene Therapy Trial at NIH for a Rare Metabolic Disease
November 19, 2024 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
- Platform Vector Gene Therapy (PaVe-GT)
Scientists at NCATS and other NIH institutes and centers are teaming up to advance a gene therapy treatment for MMA, a rare and potentially life-threatening genetic disorder.
Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology
November 19, 2024 - NCATS News
- Small Business (SBIR)
NCATS small business innovation research funding helped Spectradyne, LLC, commercialize an improved nanoparticle analyzer critical to research and drug development.